Prescription drug · ANDA
Telmisartan NDC 67296-2284
Telmisartan 20 mg/1 · Tablet · Oral · Redpharm Drug
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67296-2284-9 | 67296228409 | 90 TABLET in 1 CONTAINER (67296-2284-9)Marketed from Dec 1, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Telmisartan
- Generic name (nonproprietary)
- telmisartan
- Active ingredients
- Telmisartan — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Redpharm Drug
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203986
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 67296-2284_5743c596-7fcc-a9b5-e063-6294a90a2099SPL ID 5743c596-7fcc-a9b5-e063-6294a90a2099SPL set ID 5743c58e-deab-ac93-e063-6294a90ac1ebRxCUI 282755UNII U5SYW473RQUPC 0372603831016, 0372603832013, 0372603833010
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467296228409followed by a unit qualifier and the quantityPackage 67296-2284-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Telmisartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors ( 1.2 ) 1.1 Hypertension Telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203986
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Telmisartan | Telmisartan 40 mg/1 | TabletOral | NorthStar RxLLC | 72603-832 |
| Telmisartan | Telmisartan 20 mg/1 | TabletOral | NorthStar RxLLC | 72603-831 |
| Telmisartan | Telmisartan 80 mg/1 | TabletOral | NorthStar RxLLC | 72603-833 |
| Telmisartan | Telmisartan 40 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-119 |
| Telmisartan | Telmisartan 20 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-118 |
| Telmisartan | Telmisartan 80 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-120 |